pos5 (SPAC323.01c, UniProt Q9UT98) — review notes

2026-11-01 — initial review, centred on Nishihara et al. 2026 (PMID:41926382)

Identity and sequence-level evidence

S. cerevisiae Pos5 (ortholog; background, not S. pombe evidence)

What Nishihara et al. 2026 showed — S. pombe results

All results below are in S. pombe unless marked [Sc].

  1. CoQ10 deficiency of Δpos5. Found in a Bioneer deletion-library screen; a
    freshly constructed Δpos5 (RYP7) has 0.2-fold of WT CoQ10
    PMID:41926382.
  2. Not a secondary effect of respiratory failure (Δcyc1 control)
    PMID:41926382.
    Authors still cannot exclude an indirect Fe-S route
    PMID:41926382.
  3. Phenotypes of CoQ-deficient S. pombe: no growth on glycerol/ethanol, H2O2
    sensitivity, slow growth on minimal medium
    PMID:41926382;
    high sulfide (brown colonies on CuSO4)
    PMID:41926382;
    round cell morphology PMID:41926382.
  4. Arginine auxotrophy partially rescued by arginine (S1 Fig), attributed to NADPH
    use by Arg11 PMID:41926382.
  5. ScPOS5 complements Δpos5 CoQ (chromosomally integrated, P41nmt1)
    PMID:41926382.
  6. Mitochondrial NADP(H) is reduced in mitochondria-enriched fractions of Δpos5
    PMID:41926382.
    Caveat: modest reduction; crude mitochondrial fraction; no enzyme assay of SpPos5.
  7. Localisation. Endogenous C-terminal GFP fusion was mislocalised and
    non-functional PMID:41926382;
    plasmid-expressed Pos5-GFP co-localised with MitoTracker
    PMID:41926382.
    No sub-mitochondrial fractionation.
  8. Mitochondrial NAD kinase activity is what matters: N-terminally truncated Pos5
    (ΔMTS83) and cytosolic ScUtr1 fail, while ScUtr1 fused to the SpCoq3 MTS rescues
    PMID:41926382.
    This is the strongest (indirect) evidence that the S. pombe protein acts as an
    NAD(H) kinase in mitochondria: the defect is rescued by an unrelated NAD kinase
    only if it is targeted to mitochondria.
  9. Coq6 is not the limiting step: coq6 overexpression does not help
    PMID:41926382;
    VA tends to help (not significant)
    PMID:41926382;
    PHB partially restores
    PMID:41926382.
    atd1 overexpression: slight, non-significant increase (S7 Fig).
  10. Authors' conclusion: the NADPH-dependent step is upstream, in quinone precursor
    synthesis, and remains unidentified
    PMID:41926382.

[Sc] results in the same paper: ΔScpos5 CoQ6 is 0.2-fold of WT
PMID:41926382;
ΔScpos5 respiratory deficiency, H2O2 sensitivity and arginine auxotrophy confirmed (Fig 4A).

Not done in the paper: no in vitro kinase assay of SpPos5, no sub-mitochondrial
localisation, no CoQ intermediate profiling.

Supplementary material not accessible: S1-S7 Figs are only available as captions in
the cached text (images not available); S1 Table (primers) and S2 Table (plasmids) are
XLSX files that were not retrieved. None of these is needed for the annotation
decisions, but the S3/S5 localisation images could not be inspected.

Decision on "ubiquinone biosynthetic process" (GO:0006744)

Question: does Pos5 participate in CoQ biosynthesis, or is it necessary for it?

Other BP considerations

Annotation decisions (summary)

term evidence action
mitochondrion HDA (ORFeome) ACCEPT
mitochondrion IEA (SubCell) ACCEPT
mitochondrial matrix IBA ACCEPT
NADP+ biosynthetic process IEA ACCEPT
kinase activity IEA (ARBA) MODIFY -> NADH kinase activity
phosphotransferase activity, alcohol group as acceptor IEA (ARBA) MODIFY -> NADH kinase activity
NAD+ metabolic process IEA (InterPro) MODIFY -> NADP+ biosynthetic process
cellular response to oxidative stress IBA KEEP_AS_NON_CORE
NADH kinase activity IBA ACCEPT
NADH kinase activity IEA (RHEA/EC) ACCEPT

No NEW rows. The S. pombe IDA (plasmid Pos5-GFP, mitochondrion) and IMP (mitochondrial
NADP+ decrease, NADP+ biosynthetic process) results from PMID:41926382 would justify
experimental rows, but both terms are already in GOA (validation rejects NEW for a term
already present), so they are cited in the reasons of the existing rows and flagged here
for PomBase curation.